330 related articles for article (PubMed ID: 35053377)
1. Tackling the Behavior of Cancer Cells: Molecular Bases for Repurposing Antipsychotic Drugs in the Treatment of Glioblastoma.
Persico M; Abbruzzese C; Matteoni S; Matarrese P; Campana AM; Villani V; Pace A; Paggi MG
Cells; 2022 Jan; 11(2):. PubMed ID: 35053377
[TBL] [Abstract][Full Text] [Related]
2. From GWAS to drug screening: repurposing antipsychotics for glioblastoma.
Lin WZ; Liu YC; Lee MC; Tang CT; Wu GJ; Chang YT; Chu CM; Shiau CY
J Transl Med; 2022 Feb; 20(1):70. PubMed ID: 35120529
[TBL] [Abstract][Full Text] [Related]
3. Drug repurposing for the treatment of glioblastoma multiforme.
Abbruzzese C; Matteoni S; Signore M; Cardone L; Nath K; Glickson JD; Paggi MG
J Exp Clin Cancer Res; 2017 Nov; 36(1):169. PubMed ID: 29179732
[TBL] [Abstract][Full Text] [Related]
4. Drug Repurposing for Glioblastoma and Current Advances in Drug Delivery-A Comprehensive Review of the Literature.
Alomari S; Zhang I; Hernandez A; Kraft CY; Raj D; Kedda J; Tyler B
Biomolecules; 2021 Dec; 11(12):. PubMed ID: 34944514
[TBL] [Abstract][Full Text] [Related]
5. Multilevel Pharmacological Effects of Antipsychotics in Potential Glioblastoma Treatment.
Awuah WA; Kalmanovich J; Mehta A; Huang H; Abdul-Rahman T; Cheng Ng J; Yarlagadda R; Kamanousa K; Kundu M; Nansubuga EP; Hasan MM; Lyndin M; Isik A; Sikora V; Alexiou A
Curr Top Med Chem; 2023; 23(5):389-402. PubMed ID: 36593538
[TBL] [Abstract][Full Text] [Related]
6. Drug repurposing for glioblastoma based on molecular subtypes.
Chen Y; Xu R
J Biomed Inform; 2016 Dec; 64():131-138. PubMed ID: 27697594
[TBL] [Abstract][Full Text] [Related]
7. Repurposing psychiatric drugs as anti-cancer agents.
Huang J; Zhao D; Liu Z; Liu F
Cancer Lett; 2018 Apr; 419():257-265. PubMed ID: 29414306
[TBL] [Abstract][Full Text] [Related]
8. Repurposing antipsychotics as glioblastoma therapeutics: Potentials and challenges.
Lee JK; Nam DH; Lee J
Oncol Lett; 2016 Feb; 11(2):1281-1286. PubMed ID: 26893731
[TBL] [Abstract][Full Text] [Related]
9. Repurposing drugs for glioblastoma: From bench to bedside.
Basso J; Miranda A; Sousa J; Pais A; Vitorino C
Cancer Lett; 2018 Aug; 428():173-183. PubMed ID: 29729291
[TBL] [Abstract][Full Text] [Related]
10. Integrative rare disease biomedical profile based network supporting drug repurposing or repositioning, a case study of glioblastoma.
McGowan E; Sanjak J; Mathé EA; Zhu Q
Orphanet J Rare Dis; 2023 Sep; 18(1):301. PubMed ID: 37749605
[TBL] [Abstract][Full Text] [Related]
11. In silico repurposing of antipsychotic drugs for Alzheimer's disease.
Kumar S; Chowdhury S; Kumar S
BMC Neurosci; 2017 Oct; 18(1):76. PubMed ID: 29078760
[TBL] [Abstract][Full Text] [Related]
12. Anticancer Properties of the Antipsychotic Drug Chlorpromazine and Its Synergism With Temozolomide in Restraining Human Glioblastoma Proliferation
Matteoni S; Matarrese P; Ascione B; Buccarelli M; Ricci-Vitiani L; Pallini R; Villani V; Pace A; Paggi MG; Abbruzzese C
Front Oncol; 2021; 11():635472. PubMed ID: 33718225
[TBL] [Abstract][Full Text] [Related]
13. An Alternative Pipeline for Glioblastoma Therapeutics: A Systematic Review of Drug Repurposing in Glioblastoma.
Lyne SB; Yamini B
Cancers (Basel); 2021 Apr; 13(8):. PubMed ID: 33919596
[TBL] [Abstract][Full Text] [Related]
14. Identification of thioridazine, an antipsychotic drug, as an antiglioblastoma and anticancer stem cell agent using public gene expression data.
Cheng HW; Liang YH; Kuo YL; Chuu CP; Lin CY; Lee MH; Wu AT; Yeh CT; Chen EI; Whang-Peng J; Su CL; Huang CY
Cell Death Dis; 2015 May; 6(5):e1753. PubMed ID: 25950483
[TBL] [Abstract][Full Text] [Related]
15. Repurposing chlorpromazine in the treatment of glioblastoma multiforme: analysis of literature and forthcoming steps.
Abbruzzese C; Matteoni S; Persico M; Villani V; Paggi MG
J Exp Clin Cancer Res; 2020 Jan; 39(1):26. PubMed ID: 32005270
[TBL] [Abstract][Full Text] [Related]
16. Signature reversion of three disease-associated gene signatures prioritizes cancer drug repurposing candidates.
Fisher JL; Wilk EJ; Oza VH; Gary SE; Howton TC; Flanary VL; Clark AD; Hjelmeland AB; Lasseigne BN
FEBS Open Bio; 2024 May; 14(5):803-830. PubMed ID: 38531616
[TBL] [Abstract][Full Text] [Related]
17. Biological basis and clinical study of glycogen synthase kinase- 3β-targeted therapy by drug repositioning for glioblastoma.
Furuta T; Sabit H; Dong Y; Miyashita K; Kinoshita M; Uchiyama N; Hayashi Y; Hayashi Y; Minamoto T; Nakada M
Oncotarget; 2017 Apr; 8(14):22811-22824. PubMed ID: 28423558
[TBL] [Abstract][Full Text] [Related]
18. Drug repositioning: Using psychotropic drugs for the treatment of glioma.
You F; Zhang C; Liu X; Ji D; Zhang T; Yu R; Gao S
Cancer Lett; 2022 Feb; 527():140-149. PubMed ID: 34923043
[TBL] [Abstract][Full Text] [Related]
19. Repositioning of the antipsychotic trifluoperazine: Synthesis, biological evaluation and in silico study of trifluoperazine analogs as anti-glioblastoma agents.
Kang S; Lee JM; Jeon B; Elkamhawy A; Paik S; Hong J; Oh SJ; Paek SH; Lee CJ; Hassan AHE; Kang SS; Roh EJ
Eur J Med Chem; 2018 May; 151():186-198. PubMed ID: 29614416
[TBL] [Abstract][Full Text] [Related]
20. Discovery of Small Molecule PARKIN Activator from Antipsychotic/Anti-neuropsychiatric Drugs as Therapeutics for PD: an In Silico Repurposing Approach.
Ibrahim A; Ipinloju N; Atasie NH; Babalola RM; Muhammad SA; Oyeneyin OE
Appl Biochem Biotechnol; 2023 Oct; 195(10):5980-6002. PubMed ID: 36735144
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
